B-SOFT(SZ:300451) Sou Hu Cai Jing·2026-01-08 13:41Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Chuangyue Huikang (300451), indicating a significant decline in revenue and profit for the first three quarters of 2025 compared to the previous year [2] - As of January 8, 2026, Chuangyue Huikang's stock closed at 5.28 yuan, with a 2.92% increase, a turnover rate of 5.41%, and a trading volume of 826,600 hands, amounting to a total transaction value of 437 million yuan [1] - The company reported a main revenue of 862 million yuan for the first three quarters of 2025, a year-on-year decrease of 26.26%, and a net profit attributable to shareholders of -122 million yuan, a decline of 331.69% [2] Group 2 - In the third quarter of 2025, the company's single-quarter main revenue was 285 million yuan, down 35.5% year-on-year, with a net profit of -41.67 million yuan, reflecting a 264.2% decrease [2] - The company has shifted its main business focus from product development and sales to a broader range of services, including smart healthcare, internet medical services, medical IoT, and health city solutions [2] - Over the past 90 days, two institutions have rated the stock as a buy, with an average target price of 6.05 yuan [3]